Letaxaban
Letaxaban (TAK-442) is an orally active and selective direct FXa inhibitor. Letaxaban is a drug with dual anticoagulant and anti-inflammatory activity that works by directly inhibiting FXa and by intervening in the PAR1 signaling pathway. Letaxaban can be used in the study of thrombotic diseases, cardiovascular diseases and inflammation-related diseases[1].
Product Specifications
CAS Number
870262-90-1
Product Name Alternative
TAK-442
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Factor Xa
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/letaxaban.html
Smiles
ClC1=CC2=C(C=C1)C=C(C=C2)S(C[C@@H](O)C(N3CCC(N4C(NCCC4)=O)CC3)=O)(=O)=O
Molecular Formula
C22H26ClN3O5S
Molecular Weight
479.98
Precautions
P261-P280-P302+P352
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Mouse Glycoprotein VI, Platelet (GP6) ELISA Kit
Mouse Glycoprotein VI, Platelet (GP6) ELISA Kit
Human Solute Carrier Family 5 Member 4 (SLC5A4) ELISA Kit